Use of deep neural network ensembles to identify embryonic-fetal transition markers: repression of COX7A1 in embryonic and cancer cells
Metrics: PDF 653 views | HTML 4911 views | ?
Michael D. West1, Ivan Labat1, Hal Sternberg1, Dana Larocca1, Igor Nasonkin2, Karen B. Chapman3, Ratnesh Singh2, Eugene Makarev4, Alex Aliper4, Andrey Kazennov4,5, Andrey Alekseenko4,10, Nikolai Shuvalov4,5, Evgenia Cheskidova4,5, Aleksandr Alekseev4,5, Artem Artemov4, Evgeny Putin4,6, Polina Mamoshina4, Nikita Pryanichnikov4, Jacob Larocca1, Karen Copeland7, Evgeny Izumchenko8, Mikhail Korzinkin4 and Alex Zhavoronkov4,9
1AgeX Therapeutics, Inc., Alameda, CA, USA
2BioTime, Inc., Alameda, CA, USA
3Johns Hopkins University, Baltimore, MD, USA
4Pharmaceutical Artificial Intelligence Department, Insilico Medicine, Inc., Emerging Technology Centers, Johns Hopkins University at Eastern, Baltimore, MD, USA
5Moscow Institute of Physics and Technology, Dolgoprudny, Russia
6Computer Technologies Lab, ITMO University, St. Petersburg, Russia
7Boulder Statistics, Boulder, CO, USA
8Johns Hopkins University, School of Medicine, Department of Otolaryngology-Head and Neck Cancer Research, Baltimore, MD, USA
9The Biogerontology Research Foundation, Trevissome Park, Truro, UK
10Innopolis University, Innoplis, Russia
Michael D. West, email: firstname.lastname@example.org
Alex Zhavoronkov, email: email@example.com
Keywords: cancer marker; Warburg effect; embryonic-fetal transition; deep neural network; stem cells
Received: September 18, 2017 Accepted: December 20, 2017 Published: December 28, 2017
Here we present the application of deep neural network (DNN) ensembles trained on transcriptomic data to identify the novel markers associated with the mammalian embryonic-fetal transition (EFT). Molecular markers of this process could provide important insights into regulatory mechanisms of normal development, epimorphic tissue regeneration and cancer. Subsequent analysis of the most significant genes behind the DNNs classifier on an independent dataset of adult-derived and human embryonic stem cell (hESC)-derived progenitor cell lines led to the identification of COX7A1 gene as a potential EFT marker. COX7A1, encoding a cytochrome C oxidase subunit, was up-regulated in post-EFT murine and human cells including adult stem cells, but was not expressed in pre-EFT pluripotent embryonic stem cells or their in vitro-derived progeny. COX7A1 expression level was observed to be undetectable or low in multiple sarcoma and carcinoma cell lines as compared to normal controls. The knockout of the gene in mice led to a marked glycolytic shift reminiscent of the Warburg effect that occurs in cancer cells. The DNN approach facilitated the elucidation of a potentially new biomarker of cancer and pre-EFT cells, the embryo-onco phenotype, which may potentially be used as a target for controlling the embryonic-fetal transition.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.